Zepbound Beats Wegovy for Weight Loss
Digest more
Landmark research suggests the appetite-suppressing jabs which mimic a hormone that makes us feel full also significantly cut cancer risk by lowering inflammation
The weight-loss drug Wegovy slashes the risk of heart disease even before people shed many pounds, data suggests.The drug, which contains the active ingredient semaglutide, works by reducing food cravings and is also available for people with a high BMI.
The Trump administration on Monday singled out powerful new weight-loss drugs including Wegovy and Zepbound as targets in its push to lower prescription drug prices. President Donald Trump's executive order demands that drugmakers cut prices on their products in the coming months to hew more closely to what they charge in other developed countries,
The first head-to-head trial shows Mounjaro helps people lose more weight than its rival Wegovy as scientists confirm why it seems to work better for tackling obesity